[{"Assets_0_Q3_USD":20836000.0,"CommonStockSharesOutstanding_0_Q3_shares":17219300.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-4205000.0,"NetIncomeLoss_1_Q3_USD":-1267000.0,"NetIncomeLoss_3_Q3_USD":-5880000.0,"StockholdersEquity_0_Q3_USD":19974000.0,"Ticker":"SAVA","CIK":"1069530","name":"PAIN THERAPEUTICS INC","OfficialName":"Cassava Sciences Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"898902969.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181030"}]